NCT03900364

Brief Summary

In this trial the investigators want to examine and compare oncological and surgical outcomes of two surgical techniques in a prospective, randomised, single-blind trial. Therefore the investigators are going to include 30 patients with a renal mass who need surgical treatment. When they fulfill the inclusion criteria they get randomised either for robot-assisted partial nephrectomy or laparoscopic partial nephrectomy. Primary endpoint is the oncological outcome (residual tumor classification, TNM classification), secondary endpoints are operation time, time of ischemia, blood loss, pain after surgery, kidney function, complications and hospital stay.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 3, 2018

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 12, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 3, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2020

Completed
Last Updated

September 28, 2021

Status Verified

September 1, 2021

Enrollment Period

2.1 years

First QC Date

February 12, 2019

Last Update Submit

September 25, 2021

Conditions

Keywords

partial nephrectomyrobot-assisted partial nephrectomylaparoscopic partial nephrectomy

Outcome Measures

Primary Outcomes (1)

  • Number of participants with R0 status

    The tumor status following further treatment is described by the residual tumor classification. R0 means no residual tumor, R1 means microscopic residual tumor. The investigators are going to examine if there are any significant differences concerning tumor status between these two surgical techniques

    one year

Secondary Outcomes (7)

  • Operation time

    one year

  • Ischemia time

    one year

  • Blood loss

    one year

  • Postoperative pain

    one year

  • Kidney function

    one year

  • +2 more secondary outcomes

Study Arms (2)

robot-assisted partial nephrectomy

OTHER

partial nephrectomy performed with the da Vinci Surgical System

Procedure: partial nephrectomy

laparoscopic partial nephrectomy

OTHER

partial nephrectomy performed with conventional laparoscopic surgery

Procedure: partial nephrectomy

Interventions

Partial nephrectomy is the standard technique for organ-sparing resection of renal tumors. The EAU Guidelines recommend partial nephrectomy to all patients with T1 tumours and can be performed either with an open, pure laparoscopic or robot-assisted approach, based on surgeon's expertise and skills.

laparoscopic partial nephrectomyrobot-assisted partial nephrectomy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • minimum age of 18 years
  • solid renal mass suspicious for renal cell carcinoma or at least Bosniak III cyst
  • signed informed consent

You may not qualify if:

  • performed kidney surgery at the same side
  • Pregnancy
  • RENAL Nephrometry score III

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uniklinikum Salzburg, Department for Urology and Andrology

Salzburg, 5020, Austria

Location

MeSH Terms

Conditions

Carcinoma, Renal Cell

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsKidney NeoplasmsUrologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesKidney DiseasesUrologic DiseasesMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
single-blinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 12, 2019

First Posted

April 3, 2019

Study Start

September 3, 2018

Primary Completion

October 15, 2020

Study Completion

October 15, 2020

Last Updated

September 28, 2021

Record last verified: 2021-09

Locations